The patent rights on the world’s best-selling drug of all time, cholesterol-reducing Lipitor, have expired, opening the way for the sale of cheaper copies of the medication. U.S.-based drugmaker Pfizer has had exclusive rights to sell Lipitor since 1997, and since then has sold about $100 billion worth of prescriptions for the white, oval-shaped pills. […]
Patent Expires on Top-Selling Anti-Cholesterol Drug
Posted November 30th, 2011 at 3:35 pm (UTC-5)
Leave a comment